This document is an excerpt from the EUR-Lex website
Document 62020TJ0248
Judgment of the General Court (Sixth Chamber) of 10 November 2021.#Stada Arzneimittel AG v European Union Intellectual Property Office.#EU trade mark – Opposition proceedings – Application for the EU word mark RUXYMLA – Earlier EU word mark RUXIMERA – Relative ground for refusal – Likelihood of confusion – Similarity of the signs – Article 8(1)(b) of Regulation (EU) 2017/1001.#Case T-248/20.
Judgment of the General Court (Sixth Chamber) of 10 November 2021.
Stada Arzneimittel AG v European Union Intellectual Property Office.
EU trade mark – Opposition proceedings – Application for the EU word mark RUXYMLA – Earlier EU word mark RUXIMERA – Relative ground for refusal – Likelihood of confusion – Similarity of the signs – Article 8(1)(b) of Regulation (EU) 2017/1001.
Case T-248/20.
Judgment of the General Court (Sixth Chamber) of 10 November 2021.
Stada Arzneimittel AG v European Union Intellectual Property Office.
EU trade mark – Opposition proceedings – Application for the EU word mark RUXYMLA – Earlier EU word mark RUXIMERA – Relative ground for refusal – Likelihood of confusion – Similarity of the signs – Article 8(1)(b) of Regulation (EU) 2017/1001.
Case T-248/20.
ECLI identifier: ECLI:EU:T:2021:772